Correction to Lancet Oncol 2019; 20: 297-310
- PMID: 31162102
- DOI: 10.1016/S1470-2045(19)30348-1
Correction to Lancet Oncol 2019; 20: 297-310
Erratum for
-
Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial.Lancet Oncol. 2019 Feb;20(2):297-310. doi: 10.1016/S1470-2045(18)30778-2. Epub 2019 Jan 15. Lancet Oncol. 2019. PMID: 30658932 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
